Terms: = Lung cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
141 results:
1. Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in
Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
[TBL] [Abstract] [Full Text] [Related]
2. NR1D1-rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases.
Yin T; Zhu P; Lao IW; Yu L; Bai Q; Zhou X; Wang J
Histopathology; 2024 Mar; 84(4):661-670. PubMed ID: 38084644
[TBL] [Abstract] [Full Text] [Related]
3. Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods.
Lin X; Ma Q; Chen L; Guo W; Huang Z; Huang T; Cai YD
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130484. PubMed ID: 37805078
[TBL] [Abstract] [Full Text] [Related]
4. Menin-mll1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
Shi Q; Xu M; Kang Z; Zhang M; Luo Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
[TBL] [Abstract] [Full Text] [Related]
5. Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis.
Li J; Xiang R; Li Y; Liao Q; Liu Y
Virchows Arch; 2023 May; 482(5):813-822. PubMed ID: 37016248
[TBL] [Abstract] [Full Text] [Related]
6. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
[TBL] [Abstract] [Full Text] [Related]
7. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.
Ka-Yue Chow L; Lai-Shun Chung D; Tao L; Chan KF; Tung SY; Cheong Ngan RK; Ng WT; Wing-Mui Lee A; Yau CC; Lai-Wan Kwong D; Ho-Fun Lee V; Lam KO; Liu J; Chen H; Dai W; Lung ML
EBioMedicine; 2022 Dec; 86():104357. PubMed ID: 36371985
[TBL] [Abstract] [Full Text] [Related]
8. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract] [Full Text] [Related]
9. The bone marrow niche regulates redox and energy balance in mll::AF9 leukemia stem cells.
Viñado AC; Calvo IA; Cenzano I; Olaverri D; Cocera M; San Martin-Uriz P; Romero JP; Vilas-Zornoza A; Vera L; Gomez-Cebrian N; Puchades-Carrasco L; Lisi-Vega LE; Apaolaza I; Valera P; Guruceaga E; Granero-Molto F; Ripalda-Cemborain P; Luck TJ; Bullinger L; Planes FJ; Rifon JJ; Méndez-Ferrer S; Yusuf RZ; Pardo-Saganta A; Prosper F; Saez B
Leukemia; 2022 Aug; 36(8):1969-1979. PubMed ID: 35618797
[TBL] [Abstract] [Full Text] [Related]
10. A Study on microRNAs Targeting the Genes Overexpressed in lung cancer and their Codon Usage Patterns.
Chakraborty S; Nath D
Mol Biotechnol; 2022 Oct; 64(10):1095-1119. PubMed ID: 35435592
[TBL] [Abstract] [Full Text] [Related]
11. [Primary lung salivary gland-type duct carcinoma: a clinicopathological analysis of two cases and review of literature].
Li SL; Wu CY; Hou LK; Xie HK; Wu W; Zhang W; Zhang LP
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):218-223. PubMed ID: 35249285
[No Abstract] [Full Text] [Related]
12. Pembrolizumab Achieves a Complete Response in an NF-1 Mutated, PD-L1 Positive Malignant Peripheral Nerve Sheath Tumor: A Case Report and Review of the Benchmarks.
Larson K; Russ A; Arif-Tiwari H; Mahadevan D; Elliott A; Bhattacharyya A; Babiker H
J Immunother; 2022 May; 45(4):222-226. PubMed ID: 35020691
[TBL] [Abstract] [Full Text] [Related]
13. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of Incidental lung Nodules With Structured Recommendations and Electronic Tracking.
Bagga B; Fansiwala K; Thomas S; Chung R; Moore WH; Babb JS; Horwitz LI; Blecker S; Kang SK
J Am Coll Radiol; 2022 Mar; 19(3):407-414. PubMed ID: 34896068
[TBL] [Abstract] [Full Text] [Related]
15. [Resection of lung cancer in Old Patients - Does Demographic Change Cause a Rethink?].
Bastian KM; Koryllos A; Alkhatam A; Schuhan C; Lopez A; Stoelben E; Ludwig C
Pneumologie; 2022 Feb; 76(2):85-91. PubMed ID: 34734399
[TBL] [Abstract] [Full Text] [Related]
16. An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development.
Wang R; Liu J; Li K; Yang G; Chen S; Wu J; Xie X; Ren H; Pang Y
J Exp Clin Cancer Res; 2021 Oct; 40(1):318. PubMed ID: 34645486
[TBL] [Abstract] [Full Text] [Related]
17. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Lafage-Pochitaloff M; Gerby B; Baccini V; Largeaud L; Fregona V; Prade N; Juvin PY; Jamrog L; Bories P; Hébrard S; Lagarde S; Mansat-De Mas V; Dovey OM; Yusa K; Vassiliou GS; Jansen JH; Tekath T; Rombaut D; Ameye G; Barin C; Bidet A; Boudjarane J; Collonge-Rame MA; Gervais C; Ittel A; Lefebvre C; Luquet I; Michaux L; Nadal N; Poirel HA; Radford-Weiss I; Ribourtout B; Richebourg S; Struski S; Terré C; Tigaud I; Penther D; Eclache V; Fontenay M; Broccardo C; Delabesse E
Blood Adv; 2022 Jan; 6(2):386-398. PubMed ID: 34638130
[TBL] [Abstract] [Full Text] [Related]
18. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and kmt2a-rearranged AML.
Menghrajani K; Gomez-Arteaga A; Madero-Marroquin R; Zhang MJ; Bo-Subait K; Sanchez J; Wang HL; Aljurf M; Assal A; Bacher VU; Badawy SM; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Castillo P; Cerny J; Chhabra S; Ciurea SO; DeFilipp Z; Farhadfar N; Gadalla S; Gale RP; Ganguly S; Gowda L; Grunwald MR; Hashmi S; Hildebrandt G; Kanakry CG; Kansagra A; Khimani F; Krem M; Lazarus H; Liu H; Martino R; Michelis FV; Nathan S; Nishihori T; Olsson R; Reshef R; Rizzieri D; Rowe JM; Savani BN; Seo S; Sharma A; Solh M; Ustun C; Verdonck LF; Hourigan C; Sandmaier B; Litzow M; Kebriaei P; Weisdorf D; Zhang Y; Tallman MS; Saber W
Blood Adv; 2022 Jan; 6(3):828-847. PubMed ID: 34551064
[TBL] [Abstract] [Full Text] [Related]
19. Mutational landscape of primary pulmonary salivary gland-type tumors through targeted next-generation sequencing.
Wang F; Xi SY; Hao WW; Yang XH; Deng L; Xu YX; Wu XY; Zeng L; Guo KH; Wang HY
Lung Cancer; 2021 Oct; 160():1-7. PubMed ID: 34364112
[TBL] [Abstract] [Full Text] [Related]
20. Recruitment of KMT2C/mll3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in cancer.
Chang A; Liu L; Ashby JM; Wu D; Chen Y; O'Neill SS; Huang S; Wang J; Wang G; Cheng D; Tan X; Petty WJ; Pasche BC; Xiang R; Zhang W; Sun P
Cancer Res; 2021 Jun; 81(12):3358-3373. PubMed ID: 33853832
[TBL] [Abstract] [Full Text] [Related]
[Next]
